Related Experiment Videos
Circulating human C-reactive protein binds very low density lipoproteins
Insights
Human C-reactive protein (CRP) binds to abnormal beta-very-low-density lipoprotein (VLDL) in certain hyperlipoproteinaemia types. This calcium-dependent interaction, inhibitable by phosphorylcholine, may influence CRP's role in disease.
Area of Science:
- Biochemistry
- Immunology
- Clinical Chemistry
Background:
- C-reactive protein (CRP) is an acute-phase protein involved in innate immunity.
- Hyperlipoproteinaemia encompasses various disorders characterized by abnormal lipoprotein levels.
- The interaction between CRP and lipoproteins is not fully understood, particularly in specific hyperlipoproteinaemia subtypes.
Purpose of the Study:
- To investigate the binding interactions between native human CRP and specific lipoproteins.
- To determine the influence of different hyperlipoproteinaemia types on CRP-lipoprotein complex formation.
- To elucidate the characteristics of CRP-lipoprotein binding, including calcium dependence and inhibition.
Main Methods:
- Analysis of CRP complex formation in patient sera with various hyperlipoproteinaemia types (III, IV, V, IIa).
- In vitro experiments involving the addition of isolated lipoproteins (beta-VLDL, LDL, normal VLDL) to acute phase serum or purified CRP.
- Assessment of binding specificity using human and rabbit CRP with homologous and heterologous lipoproteins.
Main Results:
- Human CRP formed soluble complexes with abnormal beta-VLDL in sera from patients with type III, IV, and V hyperlipoproteinaemia.
- Complex formation was calcium-dependent and inhibited by free phosphorylcholine, but not observed with high LDL levels (type IIa).
- Isolated beta-VLDL induced CRP-lipoprotein complex formation in normolipoproteinaemic serum, while normal VLDL caused agglutination.
Conclusions:
- Human CRP specifically binds to abnormal beta-VLDL in certain hyperlipoproteinaemia conditions.
- The binding is calcium-dependent and sensitive to phosphorylcholine, suggesting a specific molecular interaction.
- These findings highlight a potential role for CRP-lipoprotein interactions in the pathophysiology of specific dyslipidaemias.
Abstract:
Native human CRP in solution formed complexes with the abnormal lipoprotein beta-VLDL in serum of patients with type III hyperlipoproteinaemia. CRP also formed complexes in sera from individuals with type IV and type V hyperlipoproteinaemia. The binding was calcium-dependent and inhibitable by free phosphoryl choline. No complexes were demonstrable in sera containing high LDL levels from cases of type IIa hyperlipoproteinaemia. Addition of isolated beta-VLDL, but not of isolated LDL, to acute phase normolipoproteinaemic serum caused the appearance of soluble CRP-lipoprotein complexes. In contrast, addition of an excess of isolated normal VLDL to acute phase serum or to isolated CRP was followed by agglutination (creaming) of the lipoprotein particles. Rabbit CRP, on the other hand, formed soluble complexes both with normal human apoB containing lipoproteins and with the abnormal beta-VLDL. Human CRP complexed with rabbit beta-VLDL but not with normal rabbit serum lipoproteins. These interactions may be important for the role of CRP in health and disease.